GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » Research & Development

Utah Medical Products (Utah Medical Products) Research & Development

: $0.56 Mil (TTM As of Dec. 2023)
View and export this data going back to 1999. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. Utah Medical Products's Research & Development for the three months ended in Dec. 2023 was $0.15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.56 Mil.


Utah Medical Products Research & Development Historical Data

The historical data trend for Utah Medical Products's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.49 0.53 0.49 0.56

Utah Medical Products Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.14 0.13 0.14 0.15

Utah Medical Products Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Utah Medical Products  (NAS:UTMD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Utah Medical Products Research & Development Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Utah Medical Products (Utah Medical Products) Business Description

Traded in Other Exchanges
Address
7043 South 300 West, Midvale, UT, USA, 84047
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Executives
Paul O Richins director, officer: VP, Treasurer, Asst. Secretary 7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne director
Ernst G Hoyer director
Kevin L Cornwell director, officer: Chairman, CEO, Secretary
Brian Koopman officer: Principal Financial Officer 108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson director 7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire officer: Chief Financial Officer 5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett director

Utah Medical Products (Utah Medical Products) Headlines